Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

Risk of measles transmission on aeroplanes: Australian experience 2007–2011

To the Editor: We thank Hoad and colleagues for presenting data from Australian states and territories regarding in-flight exposure to measles.1

The current cases in Queensland, Victoria and New South Wales, which have included domestic air travel,2 highlight the challenges measles still holds for Australia. Hoad et al’s report outlines the substantial public health response that such air travel events generate, despite the low likelihood of being able to use postexposure prophylaxis (PEP), measles–mumps–rubella vaccine or immunoglobulin in exposed contacts. They suggest that direct email or text messaging of passengers should be considered as an alternative to routine contact tracing, but identify that contact information is not always available to health departments.

Given this, we recommend that airlines be made responsible for alerting passengers in the event of an urgent public health concern, such as potential exposure to measles.

This would require airlines to keep travel manifests for at least 14 days after a flight. Potentially exposed passengers could be directed to a health department website providing information about PEP options,…